Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 8—August 2012

Letter

Rhodococcus erythropolis Encephalitis in Patient Receiving Rituximab

Satish R. Bagdure, Mark A. Fisher, Michael E. Ryan, and Faisal A. KhasawnehComments to Author 
Author affiliations: Texas Tech University Health Sciences Center, Amarillo, Texas, USA (S.R. Bagdure, M.E. Ryan, F.A. Khasawneh); University of Utah, Salt Lake City, Utah, USA (M.A. Fisher); and Associated Regional and University Pathologists Laboratories, Salt Lake City (M.A. Fisher)

Main Article

Table

Characteristics of 7 patients infected with Rhodococcus erythropolis

Patient no. Age, y/sex Cconcurrent condition Characteristic Reference
1 63/M Peritoneal dialysis, catheter-related peritonitis (2)
2 44/F Exacerbation of bronchiectasis (3)
3 24/M HIV/AIDS Disseminated skin infection (4)
4 82/F Chronic endophthalmitis after lens implantation (5)
5 53/F Osteomyelitis after first metatarsophalangeal joint arthrodesis (6)
6 6/M Acute lymphocytic leukemia Catheter-related bloodstream infection (7)
7 79/M Esophageal cancer Catheter-related bloodstream infection (8)

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO